Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Parkinson’s disease (PD) is a progressive neurodegenerative disease characterized by resting tremor, bradykinesia, rigidity, and postural instability that also includes non-motor symptoms such as mood dysregulation. Dopamine (DA) is the primary neurotransmitter involved in this disease, but choliner...
Autors principals: | Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, Rodrigo Portes Ureshino, Bruk Getachew, Silvia Lima Costa, Victor Diogenes Amaral da Silva, Yousef Tizabi |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
MDPI AG
2024-03-01
|
Col·lecció: | Cells |
Matèries: | |
Accés en línia: | https://www.mdpi.com/2073-4409/13/6/474 |
Ítems similars
-
Neuronal nicotinic acetylcholine receptors: Common molecular substrates of nicotine and alcohol dependence
per: Linzy M. Hendrickson, et al.
Publicat: (2013-04-01) -
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson’s disease
per: Ioannis Ugo eIsaias, et al.
Publicat: (2014-08-01) -
Manipulating midbrain dopamine neurons and reward-related behaviors with light-controllable nicotinic acetylcholine receptors
per: Romain Durand-de Cuttoli, et al.
Publicat: (2018-09-01) -
Neurotransmitter regulation of neural development: acetylcholine and nicotinic receptors
per: TORRÃO ANDRÉA S., et al.
Publicat: (2002-01-01) -
Expression and Possible Role of Nicotinic Acetylcholine Receptor ε Subunit (AChRe) in Mouse Sperm
per: Yusei Makino, et al.
Publicat: (2021-01-01)